RGEN FY 2023 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$632M-21.1% YoY

Gross Profit

$278M44.0% margin

Operating Income

$48M7.5% margin

Net Income

$36M5.6% margin

EPS (Diluted)

$0.63

Cash Flow

Operating Cash Flow

$114M

Free Cash Flow

$75M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$866M

Stockholders' Equity

$2.0B

Cash & Equivalents

$751M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$632M	$802M	-21.1%
Gross Profit	$278M	$456M	-38.9%
Operating Income	$48M	$225M	-78.8%
Net Income	$36M	$186M	-80.9%